Restrictive approach to chest X-rays provides positive outcomes for ICU

October 19, 2015

MONTRÉAL (October 19, 2015)- Researchers from Mount Sinai Beth Israel, in New York, New York, created a quality improvement initiative in 2012, recommending a restrictive approach to ordering chest x-rays (CXRs) compared with ordering them routinely. They hypothesized that this restrictive approach would significantly reduce patients' exposure to radiation and reduce ICU operating costs without adversely affecting patient outcomes.

A restrictive approach to ordering CXRs was implemented at a teaching hospital in January 2012, and a retrospective review was later conducted of all ICU patients from 2011-2014 to examine the effectiveness. Results found that a restrictive approach led to large decreases in total CXRs ordered, correcting for both total number of patients and ventilator days. No negative impact on the total number of patient ventilator days, length of stay, and other outcomes was found.

"A restrictive approach to ordering chest x-rays in the ICU appears to be a safe practice," said Dr. Jason Filopei, Mount Sinai Beth Israel physician and lead researcher. "We believe it will lead to a significant saving of hospital resources."
Further results will be shared during CHEST Annual Meeting 2015 on Wednesday, October 28, at 1:30 pm at Palais des Congrès de Montréal, in the Exhibit Hall. The study abstract can be viewed on the CHEST website.

CHEST Annual Meeting 2015 is the 81st annual meeting of the American College of Chest Physicians, held October 24-28, 2015, in Montréal, Canada. The American College of Chest Physicians, publisher of the journal CHEST, is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care. Its mission is to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. It serves as an essential connection to clinical knowledge and resources for its 18,700 members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For more information about CHEST 2015, visit, or follow the CHEST meeting hashtag, #CHEST2015, on social media.

American College of Chest Physicians

Related Radiation Articles from Brightsurf:

Sheer protection from electromagnetic radiation
A printable ink that is both conductive and transparent can also block radio waves.

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.

First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.

New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.

Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.

'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.

Read More: Radiation News and Radiation Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to